Literature DB >> 10796960

Primary aortoduodenal fistula and Q fever: an underrecognized association?

A Mejia1, B Toursarkissian, R T Hagino, J G Myers, M T Sykes.   

Abstract

We report a rare case of primary aortoduodenal fistula (ADF) secondary to a Coxiella burnetii (Q fever) infection in a patient with an abdominal aortic aneurysm. A review of the available literature on the vascular complications of Q fever is presented. Q fever should be suspected in vascular patients with close animal contact when a standard infectious work-up is unrevealing. Diagnostic steps and management strategies for primary ADF are also briefly reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 10796960     DOI: 10.1007/s100169910046

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  4 in total

Review 1.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  A Case of Primary Aortoduodenal Fistula and Abdominal Aortic Aneurysm in a Patient with Chronic Q Fever.

Authors:  Arne de Niet; Ignace F J Tielliu; Paul M van Schaik; Jan J A M van den Dungen; Clark J Zeebregts
Journal:  Aorta (Stamford)       Date:  2017-02-01

3.  Coxiella burnetii infection of aortic aneurysms or vascular grafts: report of 30 new cases and evaluation of outcome.

Authors:  E Botelho-Nevers; P-E Fournier; H Richet; F Fenollar; H Lepidi; C Foucault; A Branchereau; P Piquet; M Maurin; D Raoult
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

4.  Treatment and Prophylactic Strategy for Coxiella burnetii Infection of Aneurysms and Vascular Grafts: A Retrospective Cohort Study.

Authors:  Carole Eldin; Morgane Mailhe; Caroline Lions; Patrizia Carrieri; Hazem Safi; Philippe Brouqui; Didier Raoult
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.